secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0000950170-24-038614
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix amends bond agreement with CVI, adds beneficial ownership cap and payment deferral rights
--------------------------------------------------------------------------------

- Amendment with CVI Investments adds a 9.99% beneficial ownership limitation on bondholder's ordinary shares.
- Removes daily cap on ADS sales; shortens market price observation periods to 5 and 3 days.
- Majority bondholders (>50% principal) can defer the April 7, 2024 scheduled amortization payment.
- Majority bondholders also gain right to accelerate deferred April 2024 payment and future scheduled payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024038614/0000950170-24-038614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024038614/rnlx-20240328.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-038614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer